Effect of cytostatic agents on the adhesion of human amniotic ell lines.
D000650:Amnion; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured / Q000187:drug effects*; D002860:Chromium Radioisotopes; D003630:Daunorubicin / Q000494:pharmacology; D004896:Erythritol / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006918:Hydroxyurea / Q000494:pharmacology; D066298:In Vitro Techniques; D008357:Mannomustine / Q000494:pharmacology; D008698:Mesylates / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D008936:Mitolactol / Q000494:pharmacology; D013194:Staining and Labeling; D013501:Surface-Active Agents / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
D000970:Antineoplastic Agents; D002860:Chromium Radioisotopes; D005021:Ethylamines; D008698:Mesylates; D013501:Surface-Active Agents; D014747:Vinblastine; D008357:Mannomustine; D008936:Mitolactol; D004896:Erythritol; D006918:Hydroxyurea; D008727:Methotrexate; D003630:Daunorubicin